Wednesday, October 03, 2018 8:59:09 AM
FinCanna Investment Refined Resin Technologies Inc. Receives US$9.6 Million Minimum Purchase Order
https://globenewswire.com/news-release/2018/10/03/1600526/0/en/FinCanna-Investment-Refined-Resin-Technologies-Inc-Receives-US-9-6-Million-Minimum-Purchase-Order.html
Minimum Purchase Orders Now Total US$10.4 Million for THC Distillate
VANCOUVER, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- FinCanna Capital Corp. (“FinCanna”) (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce that its investee company Refined Resin Technologies Inc. (“Refined Resin”) of Oakland, California has acquired its second purchase order for THC distillate in the minimum amount of US$9.6 million. Refined Resin is a cannabinoid research and refinery company that provides B2B products and services to licensed brands, dispensaries and distributors in the medical cannabis supply chain.
This purchase order was received from a prominent, large volume, California cannabis enterprise whose business interests include brands, products, and a California wide distribution network. The purchase order of US$9.6 million is specified as a minimum annual amount with the expectation that monthly volumes and associated payments would significantly increase based on consistent delivery and performance.
https://globenewswire.com/news-release/2018/10/03/1600526/0/en/FinCanna-Investment-Refined-Resin-Technologies-Inc-Receives-US-9-6-Million-Minimum-Purchase-Order.html
Minimum Purchase Orders Now Total US$10.4 Million for THC Distillate
VANCOUVER, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- FinCanna Capital Corp. (“FinCanna”) (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce that its investee company Refined Resin Technologies Inc. (“Refined Resin”) of Oakland, California has acquired its second purchase order for THC distillate in the minimum amount of US$9.6 million. Refined Resin is a cannabinoid research and refinery company that provides B2B products and services to licensed brands, dispensaries and distributors in the medical cannabis supply chain.
This purchase order was received from a prominent, large volume, California cannabis enterprise whose business interests include brands, products, and a California wide distribution network. The purchase order of US$9.6 million is specified as a minimum annual amount with the expectation that monthly volumes and associated payments would significantly increase based on consistent delivery and performance.

